Top 5 Most Influential Psychedelic Studies
We unpack five of the most important psychedelic studies conducted in recent years as psychedelics become mainstream medicine.
We unpack five of the most important psychedelic studies conducted in recent years as psychedelics become mainstream medicine.
Skip the drugs, and take a trip on the screen instead.
In today’s episode, we discuss healing traumatic brain injury, also know as (TBI) with two times Stanley Cup Champion Daniel Carcillo, Founder and CEO of Wesana Health (CNSX: WESA | OTC: WSNAF)
For More Information on Wesana Health, visit:
https://www.wesanahealth.com/
Follow Wesana on Social Media:
Twitter: @wesanahealth
Instagram: @wesanahealth
Facebook: @wesanahealth
Follow us on Twitter:
@Psy_Invest
@psy_holy
@PsycSpotlight
Follow us on Instagram:
@thepsychedelicinvestor
@psycspotlight
To learn more about the emerging psychedelic industry, visit:
https://psychedelicspotlight.com/
This video was conducted on behalf of Wesana Health, and was funded by Gold Standard Media LLC and/or affiliates. For our full disclaimer, please visit: https://portal.goldstandardir.com/disclaimer/WSNAF-85
DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.
All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change.
#WesanaHealth #WESASttock #Psychedelicstocks
This week in psychedelic business news: Small Pharma prepares big DMT studies; Health Canada approves a psilocybin PTSD study.
Our resident Psychedelic Investor details five companies he thinks are in strong position to win the psychedelic medicine race.
After a disappointing microdosing study, Dr. Michiel van Elk says the trend is “just not that interesting.”
Now it’s up to the state’s Senate to consider the bill decriminalizing the possession of psilocybin and authorizing research.
These destinations give “a quick weekend trip” a whole new meaning.
Elemental Advisors Inc. CEO Tim Collins paints a picture of the past, present, and future of the psychedelics market in this guest blog.
A double-blinded, randomized, and placebo-controlled study compares the subjective and autonomic effects of both psychedelics.
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.